A61K 51/087
The peptide being an annexin
Official title: {the peptide being an annexin, e.g. annexin V}
A61K51/087 (The peptide being an annexin) appears on 44 US grants and 51 published applications in this corpus.
Search patents in A61K- Granted patents
- 44
- Published applications
- 51
- Assignees
- 29
- Inventors
- 59
- Latest grant
- 22 Jun 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 5 | 0 |
| 2002 | 0 | 3 |
| 2003 | 1 | 6 |
| 2004 | 3 | 1 |
| 2005 | 1 | 6 |
| 2006 | 2 | 2 |
| 2007 | 4 | 7 |
| 2008 | 1 | 2 |
| 2009 | 3 | 2 |
| 2010 | 3 | 3 |
| 2011 | 2 | 4 |
| 2012 | 3 | 1 |
| 2013 | 2 | 4 |
| 2014 | 4 | 4 |
| 2015 | 1 | 0 |
| 2016 | 1 | 2 |
| 2017 | 1 | 1 |
| 2018 | 1 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 2 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Anti human annexin A1 antibody22 Jun 2021US 11,041,019 B2Medannex Ltd.
- Method of diagnosing and treating Alzheimer's disease14 May 2019US 10,286,093 B2NeuroSn, Inc.
- Annexin II compositions6 Nov 2018US 10,117,928 B2Regents of the University of Minnesota
- Annexin II compositions31 Jan 2017US 9,555,074 B2Regents of the University of Minnesota
- Methods and compositions for treating luminal inflammatory disease15 Mar 2016US 9,283,290 B2SnIP Holdings, Inc.
- Lyophilized Compositions Comprising Rhannexin V-128, Process for Their Preparation and Their Use for Preparing Formulations Containing 99MTc-Rhannexin V-1283 Feb 2022US 2022/0031872 A1Advanced Accelerator Applications International SA
- Lyophilized Compositions Comprising Rhannexin V-128, Process for Their Preparation and Their Use for Preparing Formulations Containing 99MTc-Rhannexin V-1286 Feb 2020US 2020/0038526 A1Advanced Accelerator Applications International SA
- Anti human annexin a1 antibody30 Jan 2020US 2020/0031911 A1Medannex Ltd.
- Annexin ii compositions and methods11 May 2017US 2017/0128570 A1Regents of the University of Minnesota
- Treatment of immune, inflammatory and degenerative arthritides with tin-117m28 Apr 2016US 2016/0114062 A1Rheumco LLC
Most cited
By later US patents
- Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging61US 6,692,724 B1Board of Regents, The University of Texas System · 2004
- Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging46US 7,067,111 B1Board of Regents, The University of Texas System · 2006
- Method of imaging cell death in vivo40US 6,197,278 B1The Board of Trustees of the Leland Stanford Junior University · 2001
- Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging35US 7,223,380 B2Board of Regents, The University of Texas System · 2007
- Use of an anticoagulant as a diagnostic agent30US 5,627,036 ABoehringer Ingelheim International GmbH · 1997